Dr Reddys Laboratories News

Dr Reddy's Laboratories has succeeded in developing a copycat or generic version of Pfizer's Lipitor, the world's largest selling drug which has sales of over $10 billion.

The Dow rose 0.8% and regained its 50-day moving average. But the blue-chip index was up as much as 1.5% and down as much as 0.3%. Meanwhile, the NYSE composite and S&P 500 climbed 0.7% and 0.6% respectively.

The top dogs of the recent uptrend capitulated last week as the broad market took a beating.

Generic drug maker Dr. Reddy's Laboratories reported on Oct. 23 a doubling of net profit in the second quarter, aided by the launch of new drugs in overseas markets.

HYDERABAD: Dr. Reddy's Laboratories has described the reports on its take over by pharma major GlaxoSmithKline as "speculative". DRL Vice-President and Chief Executive Officer G. V. Prasad said the company had entered into a strategic tie-up with the GSK for marketing its products in the emerging markets.

Hyderabad-based pharmaceutical major Dr Reddy's Laboratories Ltd more than doubled its net profit to Rs 217 crore during the July-September quarter compared to Rs 105 crore in the same period last year, its consolidated results announced today show.

Revenues, including forex gain of Rs 24 crore, during the quarter touched Rs 1,836.8 crore, against Rs 1,615.1 crore, reflecting an increase of 14%. EPS stood at Rs 12 in Q2 FY10 as against Rs 6 in Q2 FY09.

Partners Biogen Idec and Elan Corp. led drug stocks lower early Friday as shares of the companies fell on news that European regulators were reviewing the safety of their multiple sclerosis drug Tysabri.

Hyderabad, Oct 20 : Dr Reddy's Laboratories Limited today announced that it has joined the Green Chemistry Institute Pharmaceutical Roundtable of the American Chemical Society as an Associate member.

Western drugmakers are stepping up the hunt for emerging market "tigers" in India.

New York: Indian stocks trading on American bourses gained nearly USD 4 billion last week, with IT major Wipro and private sector lender ICICI Bank pocketing most of the gains.

Pharmaceutical Major, Lupin Ltd. announced today the acquisition of US rights for Antara .

Dr Reddy's Laboratories has recalled some batches of four products from its key US market that were observed to contain some oversized tablets.

Janssen battled a gaggle of generic drug makers over "a method for treating Alzheimer's disease with galanthamine." The patent of contention was 4,663,318 . The issue before the courts was enablement , which, on appeal, the CAFC majority tied to utility for instant determination.

Indian stocks trading on American bourses lost over USD 1 billion last week, with IT bellwether Infosys accounting for most of the losses.

It was only a matter of time before speculation about GlaxoSmithKline 's intentions towards Dr.

British drugmaker GSK is in talks to pick up a 5% stake in Indian firm Dr Reddy's as the markets in the U.S. and Europe slow down UK-based pharma giant GlaxoSmithKline is in talks to pick up a 5% stake in Hyderabad-based Dr Reddy's Laboratories Pharma in order to strengthen its association with the Indian firm with whom it had signed a marketing ...

GlaxoSmithKline is in talks to buy a 5 percent stake in Indian drugmaker Dr Reddy's Laboratories in a deal likely to be valued at $150 million, an Indian newspaper reported on Friday.

The BSE Sensex seesawed on Friday as investors took profits after the market climbed to a 16-month closing high in the previous session and as a long weekend and weak regional peers weighed on sentiment.

AMRI has filed two new patent infringement lawsuits in U.S. District Court in New Jersey against Dr.